Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Silverberg

Showing results (351-360 of 667) with videos related to

Pageof 67
Sort By:
Archives of Dermatological Research|November 16, 2020
Does daily bathing or showering worsen atopic dermatitis severity? A systematic review and meta-analysisTammy Hua, Muhammad Yousaf, Eran Gwillim, et al.
The Patient|May 13, 2025
Patients' Experiences of Atopic Dermatitis and Nemolizumab Treatment: An In-Trial Interview Study Embedded in a Phase 3 Clinical Trial (ARCADIA)Jonathan I Silverberg, Dina Filipenko, Carla Dias Barbosa, et al.
The Journal of Investigative Dermatology|November 10, 2021
Generation and Validation of the Patient-Reported Outcome Measurement Information System Itch Questionnaire-Child (PIQ-C) to Measure the Impact of Itch on Life QualityAmy S Paller, Jin-Shei Lai, Kathryn Jackson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 8, 2021
Rhinitis prevalence and association with atopic dermatitis: A systematic review and meta-analysisMette Hjorslev Knudgaard, Thomas Holger Andreasen, Nanna Ravnborg, et al.
American Journal of Clinical Dermatology|October 7, 2023
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1Eric L Simpson, Andrew Blauvelt, Jonathan I Silverberg, et al.
Dermatology and Therapy|September 25, 2023
Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical TrialsHannah Penton, Sayeli Jayade, Santhani Selveindran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 15, 2017
Phenotypical Differences of Childhood- and Adult-Onset Atopic DermatitisJonathan I Silverberg, Paras P Vakharia, Rishi Chopra, et al.
The Journal of Investigative Dermatology|October 20, 2019
Development, Validation, and Interpretation of the PROMIS Itch Questionnaire: A Patient-Reported Outcome Measure for the Quality of Life Impact of ItchJonathan I Silverberg, Jin-Shei Lai, Robert W Kantor, et al.
The British Journal of Dermatology|October 17, 2025
Nearly Half of American Children with Atopic Dermatitis Experience Significant Quality of Life Impairment, Often Underestimated by ParentsJonathan I Silverberg, Charbel Skayem, Caroline Le Floc'h, et al.
Acta Dermato-Venereologica|April 8, 2022
Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic DermatitisAndreas Wollenberg, Danielle Marcoux, Jonathan I Silverberg, et al.
Pageof 67

Showing results (351-360 of 667) with videos related to

Sort By:
Pageof 67
Archives of Dermatological Research|November 16, 2020
Does daily bathing or showering worsen atopic dermatitis severity? A systematic review and meta-analysisTammy Hua, Muhammad Yousaf, Eran Gwillim, et al.
The Patient|May 13, 2025
Patients' Experiences of Atopic Dermatitis and Nemolizumab Treatment: An In-Trial Interview Study Embedded in a Phase 3 Clinical Trial (ARCADIA)Jonathan I Silverberg, Dina Filipenko, Carla Dias Barbosa, et al.
The Journal of Investigative Dermatology|November 10, 2021
Generation and Validation of the Patient-Reported Outcome Measurement Information System Itch Questionnaire-Child (PIQ-C) to Measure the Impact of Itch on Life QualityAmy S Paller, Jin-Shei Lai, Kathryn Jackson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 8, 2021
Rhinitis prevalence and association with atopic dermatitis: A systematic review and meta-analysisMette Hjorslev Knudgaard, Thomas Holger Andreasen, Nanna Ravnborg, et al.
American Journal of Clinical Dermatology|October 7, 2023
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1Eric L Simpson, Andrew Blauvelt, Jonathan I Silverberg, et al.
Dermatology and Therapy|September 25, 2023
Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical TrialsHannah Penton, Sayeli Jayade, Santhani Selveindran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 15, 2017
Phenotypical Differences of Childhood- and Adult-Onset Atopic DermatitisJonathan I Silverberg, Paras P Vakharia, Rishi Chopra, et al.
The Journal of Investigative Dermatology|October 20, 2019
Development, Validation, and Interpretation of the PROMIS Itch Questionnaire: A Patient-Reported Outcome Measure for the Quality of Life Impact of ItchJonathan I Silverberg, Jin-Shei Lai, Robert W Kantor, et al.
The British Journal of Dermatology|October 17, 2025
Nearly Half of American Children with Atopic Dermatitis Experience Significant Quality of Life Impairment, Often Underestimated by ParentsJonathan I Silverberg, Charbel Skayem, Caroline Le Floc'h, et al.
Acta Dermato-Venereologica|April 8, 2022
Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic DermatitisAndreas Wollenberg, Danielle Marcoux, Jonathan I Silverberg, et al.
Pageof 67